4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-25-036688
Options or other derivatives
- Chief Executive Officer acquired 267,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kirn David Chief Executive Officer | 2025-03-06 | Grant or award · Stock Option (Right to Buy) | +267,500 | 267,500 | D | ||
Loading xslF345X05/ownership.xml…